Cancer Updates
Dr. Surbhi Sidana discussed the topic of minimal residual disease during the CURE Educated Patient® Multiple Myeloma Summit.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal cancers.
As a caregiver, I learned that CyberKnife radiation for metastatic prostate cancer comes with psychological and physical challenges.
When Pedro Vianna, MD, was 5 years old, his mother took him to the pediatrician in their home country of Brazil. A lymph node on the left side of his neck had been swollen for weeks. While the pediatrician reassured his family that it
The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the global phase 3 MIRACLE trial.
Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to COMPANION-002 study results.
Tagrisso is associated with positive outcomes among patients with unresectable stage 3 EGFR-mutant non-small cell lung cancer.
How Counseling Supports Your Cancer Journey – A cancer diagnosis can be life-altering, affecting not just the body…. Learn more! The post How Counseling Supports Your Cancer Journey appeared first on An Oasis of Healing.
CURE spoke with Dr. William C. Huang about what kind of team may be required to treat a patient with metastatic kidney cancer.
First-line Rybrevant plus Lazcluze significantly extended overall survival versus Tagrisso in mutated, advanced or metastatic non-small cell lung cancer.
The COCOON trial regimen reduced dermatologic side effects in patients with EGFR-mutant non-small cell lung cancer, phase 2 trial data showed.
